Hepatopulmonary Syndrome (HPS) - Diagnosis and Management ...
393
Description

Hepatopulmonary Syndrome (HPS) - Diagnosis and Management Summary

 • Syndrome of intrapulmonary shunting through vasodilation/AVMs; mechanism unclear, possibly due to circulating NO

 • Presentation: shunting tends to occur at lung bases → platypnea (dyspnea when upright, relieved when supine) & orthodeoxia (upright hypoxemia, PaO2 ↓ by 4 mmHg or ≥5%), clubbing, cyanosis, hypoxemia (↓PaO2 <70-80)

 • Diagnosis: TTE with late bubbles (3-6 cardiac cycles after RA), ↑A-a gradient ≥15 (or >20 if age >64).

     o 99mTc MAA scan is alternative to TTE but more invasive, less sensitive. May be useful in quantifying shunting if severe hypoxemia and coexistent intrinsic lung disease.

     o Pulmonary angiography performed if severe hypoxemia poorly responsive to 100% O2 & areas amenable to embolization

     o PFTs can be performed to evaluate for intrinsic lung disease; ↓DLCO in HPS

 • Management: O2; no effective medical therapies; OLT can significantly improve (and reverse) HPS



#Hepatopulmonary #Syndrome #HPS #Diagnosis #Management #Summary #Hepatology
Contributed by

MGH White Book Manual
@MGHWhiteBook
Account created for the MGH Internal Medicine Housestaff Manual "White Book" - https://stk10.github.io/MGH-Docs/WhiteBook-2019-2020.pdf
0 Comments

Related content